A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant <i>TP53</i> and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years

Eric D. Eisenmann, Ronan Swords, Ying Huang, Shelley Orwick, Daelynn Buelow, Nicole Abbott, Mitch Phelps, Joshua Zeidner, Matthew C. Foster, Tara L. Lin, Maria R. Baer, Yazan F. Madanat, Tibor Kovacsovics, Robert Redner, Zeina Al-Mansour, Bhavana Bhatnagar, Mona Stefanos, Molly Martycz, Franchesca Druggan, Timothy L. Chen, Ashley O. Yocum, Uma Borate, Brian J. Druker, Amy Burd, Ross L. Levine, John C. Byrd, Sharyn D. Baker, Alice S. Mims

Open source

DOI: 10.1158/2767-9764.crc-25-0091
Published: 2025-07-01
Container: Cancer Research Communications
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-25-0091,
  title = {A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant
                    <i>TP53</i>
                    and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years},
  author = {Eric D. Eisenmann and Ronan Swords and Ying Huang and Shelley Orwick and Daelynn Buelow and Nicole Abbott and Mitch Phelps and Joshua Zeidner and Matthew C. Foster and Tara L. Lin and Maria R. Baer and Yazan F. Madanat and Tibor Kovacsovics and Robert Redner and Zeina Al-Mansour and Bhavana Bhatnagar and Mona Stefanos and Molly Martycz and Franchesca Druggan and Timothy L. Chen and Ashley O. Yocum and Uma Borate and Brian J. Druker and Amy Burd and Ross L. Levine and John C. Byrd and Sharyn D. Baker and Alice S. Mims},
  year = {2025},
  journal = {Cancer Research Communications},
  doi = {10.1158/2767-9764.crc-25-0091},
  url = {https://doi.org/10.1158/2767-9764.crc-25-0091}
}

RIS

TY  - JOUR
TI  - A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant
                    <i>TP53</i>
                    and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years
AU  - Eric D. Eisenmann
AU  - Ronan Swords
AU  - Ying Huang
AU  - Shelley Orwick
AU  - Daelynn Buelow
AU  - Nicole Abbott
AU  - Mitch Phelps
AU  - Joshua Zeidner
AU  - Matthew C. Foster
AU  - Tara L. Lin
AU  - Maria R. Baer
AU  - Yazan F. Madanat
AU  - Tibor Kovacsovics
AU  - Robert Redner
AU  - Zeina Al-Mansour
AU  - Bhavana Bhatnagar
AU  - Mona Stefanos
AU  - Molly Martycz
AU  - Franchesca Druggan
AU  - Timothy L. Chen
AU  - Ashley O. Yocum
AU  - Uma Borate
AU  - Brian J. Druker
AU  - Amy Burd
AU  - Ross L. Levine
AU  - John C. Byrd
AU  - Sharyn D. Baker
AU  - Alice S. Mims
PY  - 2025
JO  - Cancer Research Communications
DO  - 10.1158/2767-9764.crc-25-0091
UR  - https://doi.org/10.1158/2767-9764.crc-25-0091
ER  -

APA

Eisenmann, E. D., Swords, R., Huang, Y., Orwick, S., Buelow, D., Abbott, N., Phelps, M., Zeidner, J., Foster, M. C., Lin, T. L., Baer, M. R., Madanat, Y. F., Kovacsovics, T., Redner, R., Al-Mansour, Z., Bhatnagar, B., Stefanos, M., Martycz, M., Druggan, F., Chen, T. L., Yocum, A. O., Borate, U., Druker, B. J., Burd, A., Levine, R. L., Byrd, J. C., Baker, S. D., & Mims, A. S. (2025). A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant <i>TP53</i> and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-25-0091

Source records

crossref · retrieved 2026-11-05T04:33:36.468Z